¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contrast agent nephrotoxicity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® anti-inflammatory agent ÇÑ±Û Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
¼³¸í   
  ±¹¼Ò¿¡ ÀÛ¿ëÇÏ¿© ¿°ÁõÀ» Ä¡·áÇÏ°í ¹æÁöÇϴ ¾à. ¿°ÁõÀ» °¡¶ó¾ÉÈ÷´Â ¾àÀ» ¸»ÇÑ´Ù. Á¶Á÷À» ±äÃà-Ä¡¹ÐÇϰԠÇÏ¿© Àå¾×°ú Á¡¾×ÀÇ ºÐºñ¸¦ ÁÙÀ̰í, Ç¥¸é¿¡ Àִ ÀÛÀº Ç÷°ü¿¡ ºóÇ÷À» ÀÏÀ¸ÄÑ ÃæÇ÷µÇ´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ¿°ÁõÀû º´º¯À» Á¦°ÅÇÏ¿© ¸ðµç Áõ¼¼¸¦ ¾ø¾Ø´Ù. ´ëºÎºÐÀÇ ¼ö·ÅÁ¦-¿ÏÈ­Á¦-Áø¾çÁ¦°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. Áß¿äÇÑ ¼ººÐÀ¸·Î´Â ¾Ë·ç¹Ì´½-ºñ½º¹«Æ®-¾Æ¿¬-³³È­ÇÕ¹°(º´¹Ý-Æä¸£¸¶Åç-¾Æ¿¬È­-¿¬´ç µî) µîÀÌ ÀÖ´Ù. ÀÛ¿ë¿¡ µû¶ó Ç׿°ÁõÁøÅëÁ¦¿Í Ç׿°ÁõÈ¿¼ÒÁ¦·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contrast stain
    ´ëÁ¶¿°»ö
  • contrast staining
    ´ëÁ¶¿°»ö(¹ý)
  • contrast to noise ratio
    ´ëÁ¶´ëÀâÀ½ºñ
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • double contrast radiography
    ÀÌÁßÁ¶¿µ¹æ»ç¼±ÃÔ¿µ(¼ú)
  • double-contrast barium enema
    ÀÌÁßÁ¶¿µ¹Ù·ý°üÀå
  • hepatorenal echo contrast
    °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶, °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • proton density contrast
    ¾ç¼ºÀڹеµ´ëÁ¶
  • phase contrast
    À§»ó´ëÁ¶
  • simultaneous contrast
    µ¿½Ã´ëÁ¶
  • taste contrast
    ¸À´ëÁ¶
  • anorectic agent
    ½Ä¿å¾ïÁ¦Á¦
  • antiallergic agent
    ¾Ë·¹¸£±â¾à
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hyperosmotic agent
    °í»ïÅõ¾ÐÁ¦
  • induction agent
    À¯µµ¹°Áú
  • infectious agent
    °¨¿°Ã¼, °¨¿°¿ø
  • oxidizing agent
    »êÈ­Á¦
  • pressor agent
    ½Â¾ÐÁ¦, Ç÷¾Ð»ó½ÂÁ¦
  • sclerosing agent
    °æÈ­Á¦
  • tocolytic agent
    ÀڱüöÃà¾ïÁ¦Á¦
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contrast stain
    ´ëÁ¶¿°»ö
  • contrast staining
    ´ëÁ¶¿°»ö
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • contrast to noise ratio
    ´ëÁ¶ÀâÀ½ºñ
  • good contrast
    ¶Ñ·ÇÇÑ´ëÁ¶µµ
  • hepatorenal echo contrast
    °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶, °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ, ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • phase contrast
    À§»ó´ëÁ¶
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • simultaneous contrast
    µ¿½Ã´ëÁ¶
  • successive contrast
    ¹Ýº¹´ëÁ¶
  • taste contrast
    ¸À´ëÁ¶
  • tissue contrast
    Á¶Á÷´ëÁ¶µµ
  • double contrast radiography
    ÀÌÁßÁ¶¿µ¹æ»ç¼±ÃÔ¿µ¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Eaton agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ° º´¿øÃ¼
  • Eatons agent pneumonia
    ÀÌÆ°º´¿øÃ¼Æó·Å.
  • Norwalk agent
    ³ë¿öÅ© º´¿øÃ¼
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • Pittsburgh pneumonia [agent]
    ÇÇÃ÷¹ö±×Æó·Å(¿øÀÎü), ·¹Áö¿À³Ú¶óÁõ(¿øÀÎü)
  • addition agent
    ÷°¡Á¦(ôÕÊ¥ð¥).
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶ÃëÁ¦.
  • anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥).
  • anorexiant =anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥), ½Ä¿å¾ïÁ¦Á¦.
  • anorexigenic agent
    ½Ä¿å¾ïÁ¦Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contrast echocardiography
    ¹æ»ç Á¶¿µ½ÉÃÊÀ½ÆÄ°Ë»ç.
  • contrast enema
    Á¶¿µ°üÀå(ðãç¯Î´ ).
  • contrast enema
    Á¶¿µ °üÀå
  • contrast enhancement
    Á¶¿µ Áõ°­
  • contrast enhancement ratio
    Á¶¿µ Áõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­ ½ºÄµ
  • contrast material
    Á¶¿µÁ¦
  • contrast media
    Á¶¿µÁ¦
  • contrast sensitivity
    ´ëºñ°¨µµ
  • contrast sensitivity chart
    ´ëºñ°¨µµÇ¥
  • contrast staining
    ´ëÁ¶¿°»ö
  • contrast to noise ratio
    ´ëÁ¶ ÀâÀ½ºñ
  • double contrast arthrography
    ÀÌÁß Á¶¿µ °üÀýÁ¶¿µ¼ú
  • double contrast arthrography
    °üÀý ÀÌÁß Á¶¿µ¼ú.
  • double contrast radiography
    ÀÌÁß Á¶¿µ ¹æ»ç¼±ÃÔ¿µ¼ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • denaturing agent
    º¯¼ºÁ¦(ܨàõð¥)
  • eluting agent
    ¿ë¸®Á¦(éÁ×îð¥)
  • emulsifying agent
    ¿¡¸ÖÁ¯È­Á¦(ûùð¥)
  • F agent
    F Á¦(ð¥)
  • fusogenic agent
    À¶ÇÕ »ý¼ºÁ¦(ë×ùêßæà÷ð¥)
  • germicidal agent
    »ì±ÕÁ¦(߯жð¥)
  • immunosuppressive agent
    ¸é¿ª¾ï¾ÐÁ¦(Øóæ¹åääâð¥)
  • lipotropic agent
    ÁöÁúµ¿¿øÁ¦(ò·òõÔÑê¬ð¥)
  • lympholytic agent
    ¸²ÇÁ±¸¿ëÇØÁ¦(éÁú°ð­)
  • lysosomotropic agent
    ¶óÀ̼ÒÁ»ÀÚ±ØÁ¦(í©Ð»ð¥)
  • methylating agent
    ¸ÞƿȭÁ¦(ð¥)
  • mutagenic agent
    º¯ÀÌ¿øÁ¦(ܨì¶ê«ð¥)
  • oxidizing agent
    »êÈ­Á¦(ß«ûùð¥)
  • precipitating agent
    ħ°­Á¦(öØË½ð¥)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦(úìäâß¾ã°ð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radioopaque agent
    ¹æ»ç¼±ºñÅõ°ú¼ºÁ¦Àç
  • radioprotective agent
    ¹æ»ç¼±¹æÈ£Á¦
  • sclerosing agent
    °æÈ­¾à
  • therapeutic agent
    Ä¡·á¾à
  • thrombolytic agent
    Ç÷Àü¿ëÇØ¾à
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • blood oxygenation level dependant contrast
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
  • CE [=contrast enhancement]
    Á¶¿µÁõ°­
  • CE FAST [=contrast enhanced fast acquisition in the steady state]
    Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°­°í¼Óȹµæ
  • contrast
    ´ëÁ¶, ´ëºñ, Á¶¿µ
  • contrast enema
    Á¶¿µ°üÀå
  • contrast enhancement [=CE]
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CCT carotid compression tomography; central conduction time; cerebrocranial trauma; chocolate-coated tab...
CECT contrast-enhanced computed tomography
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
CNR cannabinoid receptor; Center for Nursing Research; contrast-to-noise ratio; Council of Nurse Researc...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FWA fluorescent whitening agent
NMBA Neuromuscular blocking agent
SMA Snow Mountain Agent
AA alkylating agent
BCA bifunctional chelating agent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • radiographic contrast
    ¹æ»ç¼± »çÁø ´ëÁ¶
  • radiopaque contrast medium
    ¹æ»ç¼± ºÒÅõ°ú¼º Á¶¿µÁ¦
  • single contrast arthrogram
    ´ÜÀÏ ´ëºñ °üÀý Á¶¿µ »çÁø
  • single-contrast arthrography
    ´ÜÀÏ °üÀý Á¶¿µ¼ú
    °üÀý ¿øÆÇÀÇ À§Ä¡, ¿¬Á¶Á÷ ¿ÜÇü, õ°øÀÇ À¯¹«, °üÀý ¿îµ¿, °üÀý³» À̹°Áú, À¯Âø¼º °üÀý³¶¿°À» Æ÷ÇÔÇÏ´Â °üÀý³» ¿¬Á¶Á÷ÀÇ À§Ä¡¿Í ¿ÏÀü¼ºÀ» È®ÀÎÇϱâ À§ÇØ °üÀý°­ ³»¿¡ ¹æ»ç¼± ºÒÅõ°ú¼º Á¶¿µÁ¦¸¦ ÁÖ»çÇÑ ÈÄ ÃÔ¿µÇÑ °üÀý »çÁø.
  • tissue contrast
    Á¶Á÷ ´ëÁ¶µµ
  • water soluble contrast media
    ¼ö¿ë¼º Á¶¿µÁ¦
  • abetting agent
    Á¶Àå¹°
    ÁÖ ¾à¹°ÀÇ ¾àÈ¿¸¦ º¸Á¶Çϰí, ÁÖ ¾à¹°ÀÇ À¯ÇØÇÑ ÀÛ¿ëÀ» ¸·°Å³ª ¿ÏÈ­ÇÏ´Â ¸ñÀûÀ¸·Î »ç¿ëÇÏ´Â ¾à¹°.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸° Â÷´ÜÁ¦
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¿¡ ÀÛ¿ëÇÏ¿© ½Å°æ Àü´Þü¿Í ¼ö¿ëü°¡ °áÇÕÇÏÁö ¸øÇÏ°Ô ÇÔÀ¸·Î½á ±³°¨½Å°æ ÈïºÐ È¿°ú¸¦ ºÀ¼âÇÏ´Â ¾à¹°.
  • agent
    ¾à¹°, ¾à¹°Á¦, ÀÛ¿ë¹°Áú, º´ÀÎ
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • anabolic agent
    µ¿È­ ¾à¹°
  • analgesic agent
    ÁøÅëÁ¦
    ½Å°æÀ» ¸¶ºñ½ÃÄÑ ¾ÆÇÄÀ» ÁøÁ¤½ÃŰ´Â ¾àÁ¦. ¸ôÇÉ, ¾ÈƼÇǸ° µîÀÌ ÀÖ´Ù.
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶Ãë, ¸¶ÃëÁ¦
    µ¿ÀǾî=anesthetic drug.
  • anorexigenic agent
    ½Ä¿å ¾ïÁ¦Á¦
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
colour-contrast microscope <instrument> A type of microscope in which the condenser stop is of one colour and the annulus is a complement of it so that unstained objects are observed in one colour on a field of the other.
(05 Mar 2000)
contrast A dye injected intravenously during X-ray studies, for example CT, to enhance the image of a tumour. In MR studies, the contrast is called gadolinium. The use of contrast may rarely result in some adverse effects: it also increases the cost (but also accuracy in many cases) of the scan.
(16 Dec 1997)
contrast bath A bath in which a part is immersed in hot water for a period of a few minutes and then in cold, the hot and cold periods alternated regularly at intervals, usually half-hours; used to increase the blood flow to the part.
(05 Mar 2000)
contrast echocardiography The injection of contrast media of high echo reflectants (e.g., bubbles) to outline a chamber or delineate a shunt within the heart.
(05 Mar 2000)
contrast enema Enema using barium or another contrast medium.
(05 Mar 2000)
contrast enhancement The intravenous administration of water-soluble iodinated contrast material, which increases the CT number of the vascular pool, as well as some lesions (particularly in the brain), due to abnormal leakage into the interstitium; the property of showing increased radiopacity from concentration of contrast medium.
(05 Mar 2000)
contrast material A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
contrast media <radiology> Side-effects from high osmolality / viscosity (fluid shifts from different compartments), vasodilatation, heat, pain, osmotic diuresis, haemodynamic changes, pharmacokinetics, distribute volume into extracellular space, clearance by glomerular filtration and renal excretion, physiologic reaction, increased plasma osmolality causes fluid shift from RBCs and pulmonary tissue leading to increased plasma volume, then osmolar gradient reverses with passage of contrast bolus to pulmonary capillary endothelium leaks protein into pulmonary interstitium leading to increased pulmonary oedema, transient cardiovascular changes (magnitude increased with tonicity of medium), increased PAP, increased CO with decreased peripheral/pulmonary vascular resistance, decreased systemic arterial pressure (variable), may activate gen receptors causing side effects
(12 Dec 1998)
contrast medium A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
contrast sensitivity The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease.
(12 Dec 1998)
contrast stain <technique> A dye used to colour one portion of a tissue or cell which remained unaffected when the other part was stained by a dye of different colour.
Synonym: differential stain.
(05 Mar 2000)
contrast transfer function <microscopy> A mathematical function that expresses the ability of an optical or electronic device to transfer signals faithfully as a function of the spatial or temporal frequency of the signal.
The modulation transfer function is the ratio of percentage modulation of a sinusoidal signal leaving to that entering the device over the range of frequencies of interest. The modulation transfer function is usually presented as a graph of modulation transfer function versus log (frequency). For a square wave signal, the function is known as the CTF.
Acronym: MTF
(26 Mar 1998)
high osmolar contrast medium Ionic water-soluble iodinated contrast media.
Synonym: high osmolar contrast medium.
(05 Mar 2000)
simultaneous contrast The enhancement of the visual sensation of white when a white object is viewed adjacent to a black object; the black object also appears blacker as a result of the contiguity of white. Adjacent complementary colours also appear brighter; e.g., green appears a brighter green and red a brighter red if these two colours are viewed side by side.
(05 Mar 2000)
non-ionic contrast media <radiology> A class of radiographic contrast media which do not ionise in solution, thereby decreasing effective osmolarity and toxicity.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double agent
    ÀÌÁß °£Ã¸
  • estate agent
    ºÎµ¿»ê°ü¸®ÀÎ;Áß°³¾÷ÀÚ
  • fiscal agent
    À繫 ´ë¸® ±â°ü;À繫 ´ë¸®ÀÎ
  • forwarding agent
    ¿î¼Û¾÷ÀÚ
  • free agent
    ÀÚÁÖÀûÀÎ ÇàÀ§ÀÚ;ÀÚÀ¯°è¾à ¼±¼ö )
  • general agent
    ÃѴ븮ÀÎ
  • house agent
    º¹´ö¹æ;°¡¿Á ¸Å¸Å ¼Ò°³¾÷ÀÚ
  • inquiry agent
    (¿µ)»ç½Ç ŽÁ¤
  • insurance agent
    º¸Çè´ë¸®Á¡
  • land agent
    ÅäÁö ¸Å¸Å Áß°³¾÷ÀÚ;ÅäÁö °ü¸®ÀÎ
  • nerve agent
    (±º¿ëÀÇ)½Å°æ°è¿¡ ÀÛ¿ëÇÏ´Â ¹°Áú;½Å°æ°¡½º(µî)
  • parliamentary agent
    Á¤´çÀÇ ÀÇȸ ´ëº¯ÀÎ
  • press agent
    º¸µµ¿ø;¼±Àü¿ø
  • publicity agent
    ±¤°í ´ë¸®¾÷ÀÚ
  • purchasing agent
    ±¸¸Å ´ã´ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á